510(k) Report

FDA applicant

Seradyn, Inc.

Indianapolis, IN30 decisions1988–20071 recall

FDA records 30 decisions for Seradyn, Inc. (Indianapolis, IN) from 1988 to 2007: 30 510(k) clearances. Most are in product codes LCD (Enzyme Immunoassay, Gentamicin) and LEG (Enzyme Immunoassay, Valproic Acid). Its devices cite 10 predicates, 1 of them its own earlier devices. 1 recall is linked to its devices.

FDA’s records also spell it “Seradyn”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical toxicology panel, where it files most

How often FDA has decided Seradyn, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2007

2007: 2
2007high 2 (2007) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

1in 2007

2007: 1
2007high 1 (2007) · low 0 (2008)2026

Class I Class II/III not classified

FIG. 1 — Seradyn, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Seradyn, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report